FOSL1 and neoplasm: The selective enrichment and colocalization with beta-catenin and other EMT markers of the PKC-theta-phosphorylated protein (FRA-1-phospho-T217) at the tumor stroma interface suggest that FRA-1 participates in the gain of mesenchymal features and stemness in response to PKC-theta in invasive breast cancer [48].